The Claim
In overweight adults with type 2 diabetes, the acute uric acid excretion response to exenatide infusion is not influenced by baseline plasma uric acid levels.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In overweight adults with type 2 diabetes, a single dose of exenatide causes uric acid to be excreted in the same way regardless of how much uric acid was already in the blood before the dose.
See the scientific wording
In overweight adults with type 2 diabetes, the acute uric acid excretion response to exenatide infusion is not influenced by baseline plasma uric acid levels, suggesting the effect is independent of pre-existing hyperuricemia.
When exenatide activates receptors in the kidney, it reduces sodium reabsorption and makes urine less acidic. Less sodium reabsorption means more sodium flows to parts of the kidney that handle uric acid, which pushes uric acid out in the urine. Less acidity in the urine also stops uric acid from being pulled back into the blood, so more of it leaves the body.
What the research says
1 studyEven if someone already had high uric acid levels, giving them exenatide still made their kidneys flush out more uric acid—so their starting level didn’t change how much the drug helped.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.